Cancer drug bonanza hits Australia

Treatments for advanced cancers of the lung and cervix and advanced melanoma are included in the latest TGA and PBS listings, along with a new approach for the rare blood cancer myelofibrosis.

The TGA has approved bevacizumab for advanced cervical cancer, after a clinical trial showed it prolonged survival by a median of 3.7 months in the difficult-to-treat condition.

It is the first biologic agent